Cargando…
Coronavirus disease 2019 drug discovery through molecular docking
Background: The dawn of the year 2020 witnessed the spread of the highly infectious and communicable disease coronavirus disease 2019 (COVID-19) globally since it was first reported in 2019. Severe acute respiratory syndrome coronavirus-2 is the main causative agent. In total, 3,096,626 cases and 217...
Autores principales: | Singh, Sweta, Florez, Hector |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361499/ https://www.ncbi.nlm.nih.gov/pubmed/32704354 http://dx.doi.org/10.12688/f1000research.24218.1 |
Ejemplares similares
-
Molecular Docking: Shifting Paradigms in Drug Discovery
por: Pinzi, Luca, et al.
Publicado: (2019) -
Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking
por: Ruan, Xiaofeng, et al.
Publicado: (2020) -
Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2020) -
Novel coronavirus 2019: in-silico vaccine design and drug discovery
por: Kumar, Amit, et al.
Publicado: (2020) -
Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs
por: Chen, Guilin, et al.
Publicado: (2020)